Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02969902
Other study ID # RC 19/13
Secondary ID
Status Completed
Phase N/A
First received November 17, 2016
Last updated August 16, 2017
Start date November 2014
Est. completion date February 2015

Study information

Verified date August 2017
Source IRCCS Burlo Garofolo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Venipuncture is one of the most common iatrogenic painful and stressful procedures performed on children. Interventions aimed at reducing the distress related to this experience are widely and strongly recommended. Pain and anxiety management is even more essential because it may modify children's memory for procedural pain and the subsequent acceptance of later health care painful interventions. Distraction is the most studied psychological technique to relieve venipuncture related pain and distress, with a strong evidence supporting its efficacy in children and adolescents.

In recent years several studies showed the effectiveness of a specific tool named Buzzy® (MMJ Labs, Atlanta GA, USA), in relieving pain and distress in children. Buzzy combines distraction and physical analgesia (vibration and cold) and it was positively tested during venipuncture, intravenous cannulation and painful injections in children. Even though its efficacy it's well established, most of the published trials did not compare Buzzy with other interventions, so that little data are available about its usefulness compared with other distractions techniques.

Hand-held computers are reusable tools, which offer a technological-based active distraction. There is evidence supporting their used during painful procedures such as venipuncture and a recent published study showed that hand-held computer distraction was as effective as nurse-led passive distraction techniques in children.

The aim of this study is to compare the effectiveness of Buzzy versus hand-held computer in pain relief during venipuncture.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender All
Age group 4 Years to 12 Years
Eligibility Inclusion Criteria:

- children from 4 to 12 years of age needing venipuncture

Exclusion Criteria:

- the presence of damage, denuded or broken skin in the site of Buzzy application;

- use of topical, enteral or parenteral analgesics within eight hours before enrolment;

- the presence of cognitive impairment or the inability to report pain verbally;

- the presence of chronic disease, included epilepsy, or of diseases associated with cold hypersensitivity (i.e., sickle cell anaemia, Raynaud's disease).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Buzzy® device

Hand-held computer


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
IRCCS Burlo Garofolo

Outcome

Type Measure Description Time frame Safety issue
Primary Self-reported pain Children from 4 to 7 years of age record their pain using the Faces Pain Scale-Revised (FPS-R); children from 8 to 12 years using a Numerical Rating Scale, with scores from zero to 10. Within 5 minutes after the procedure
Secondary Pain evaluated by parents Pain evaluated using a Numerical Rating Scale, with scores from zero to 10 Within 5 minutes after the procedure
Secondary Pain evaluated by nurses Pain evaluated using a Numerical Rating Scale, with scores from zero to 10 Within 5 minutes after the procedure
Secondary Success at first attempt Percentage of success at first attempt Intraprocedural
Secondary Adverse events The number and the type of adverse events Up to 15 minutes after the procedure
See also
  Status Clinical Trial Phase
Completed NCT02901561 - Comparison Between 2 Doses of Misoprostol Before Intrauterine Device Phase 2/Phase 3
Completed NCT02905045 - Efficacy of Ketoprofen Before Hysterosalpingography Phase 3
Completed NCT02905058 - Efficacy of Ketoprofen Before Intrauterine Device Insertion Phase 3
Recruiting NCT00773760 - MOR and COMT SNP Polymorphism and Pain N/A
Completed NCT03733015 - Daily Sessions of rTMS to the Left DLPFC Modulate the Pain Thresholds and CPM N/A
Completed NCT02943135 - Lidocaine In-situ Gel Before Intrauterine Device Insertion Phase 3
Completed NCT04473508 - Erectus Nerve Block for Lumbar Spine Surgery Phase 3
Enrolling by invitation NCT03184649 - Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection (RCT) Phase 1/Phase 2
Completed NCT02614391 - Tablet Distraction for Pain Control During Venipuncture Phase 3
Recruiting NCT00768014 - fMRI Measurements on Pain Relief Methods in First Stage Labor Pain N/A
Not yet recruiting NCT04781777 - Effect of Ultrasonographic Guided Insulin Injection With Dexamethasone and Local Anesthetic Mixture in Diabetic Patients With Mild to Moderate Carpal Tunnel . N/A
Completed NCT04586712 - Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury Phase 2
Recruiting NCT06456177 - Nociception Monitoring During Epidural Analgesia
Recruiting NCT00914498 - The Effect of Pre-incisional Local Xylocaine Injection on Post Operative Pain and Scar Formation After Cesarean Section N/A
Completed NCT00638274 - Comparison of Loss of Resistance Techniques Phase 2
Recruiting NCT04656821 - Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes Zoster Phase 4
Withdrawn NCT01263652 - Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients N/A
Completed NCT01925469 - Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram Phase 4
Completed NCT00580489 - Lifeflight: Fentanyl Versus Morphine N/A
Completed NCT03263884 - Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain N/A